ES8101647A1 - Un metodo de determinacion de ligandos en muestras de ensayo - Google Patents

Un metodo de determinacion de ligandos en muestras de ensayo

Info

Publication number
ES8101647A1
ES8101647A1 ES488263A ES488263A ES8101647A1 ES 8101647 A1 ES8101647 A1 ES 8101647A1 ES 488263 A ES488263 A ES 488263A ES 488263 A ES488263 A ES 488263A ES 8101647 A1 ES8101647 A1 ES 8101647A1
Authority
ES
Spain
Prior art keywords
enzyme inhibitor
ligand analog
ligand
irreversible enzyme
irreversible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES488263A
Other languages
English (en)
Other versions
ES488263A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of ES8101647A1 publication Critical patent/ES8101647A1/es
Publication of ES488263A0 publication Critical patent/ES488263A0/es
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4071Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075Esters with hydroxyalkyl compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/825Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO DE DETERMINACION DE LIGANDOS EN MUESTRAS DE ENSAYO. CONSTA DE LAS SIGUIENTES ETAPAS: 1) REACCION CON LA MUESTRA DE ENSAYO DE UN REACTIVO CONTENIENDO UN CONJUNTO DE LIGANDO ANALOGO-INHIBIDOR IRREVERSIBLE DE UNA ENZIMA, TAL COMO LA ACETILCOLINESTERASA Y UNA PROTEINA LIGANTE COMBINABLE CON EL LIGANDO Y EL CONJUGADO DE LIGANDO ANALOGO-INHIBIDOR QUE ES IRREVERSIBLE INHIBIDO DE ENZIMA ORGANOFOSFERICO. 2) REACCION DEL ENZIMA QUE ES IRREVERSIBLE INHIBIDO POR EL CONJUGADO DE LIGANDO ANALOGO-INHIBIDOR IRREVERSIBLE DEL ENZIMA NO UNIDO A LA PROTEINA LIGANTE. 3) REACCION DE UN SUBSTRATO CON EL ENZIMA MIDIENDO LA REACCION ENZIMA-SUBSTRATO. LA MUESTRA DE SUERO SE TRATA PARA INACTIVAR O ELIMINAR A LA COLINESTARASA SERICA. EL SUBSTRATO ENZIMATICO ES ACETILTIOCOLINA.
ES488263A 1979-02-05 1980-02-04 Un metodo de determinacion de ligandos en muestras de ensayo Granted ES488263A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/009,007 US4273866A (en) 1979-02-05 1979-02-05 Ligand analog-irreversible enzyme inhibitor conjugates and methods for use

Publications (2)

Publication Number Publication Date
ES8101647A1 true ES8101647A1 (es) 1980-12-16
ES488263A0 ES488263A0 (es) 1980-12-16

Family

ID=21735028

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488263A Granted ES488263A0 (es) 1979-02-05 1980-02-04 Un metodo de determinacion de ligandos en muestras de ensayo

Country Status (15)

Country Link
US (1) US4273866A (es)
JP (1) JPS55104896A (es)
AT (1) AT365781B (es)
AU (1) AU528592B2 (es)
BE (1) BE881557A (es)
CA (1) CA1137077A (es)
CH (1) CH641569A5 (es)
DE (1) DE3003959C2 (es)
ES (1) ES488263A0 (es)
FR (1) FR2447966A1 (es)
GB (1) GB2043245B (es)
IT (1) IT1130254B (es)
NL (1) NL8000698A (es)
SE (1) SE448259B (es)
ZA (1) ZA80371B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay
DE3006709A1 (de) * 1980-02-22 1981-08-27 Hans A. Dipl.-Chem. Dr. 8000 München Thoma Homogenes verfahren zur kompetitiven bestimmung von liganden
US4341865A (en) * 1980-07-21 1982-07-27 Abbott Laboratories Determination of thyroxine binding globulin
US4849353A (en) * 1980-09-30 1989-07-18 Cornell Research Foundation, Inc. Immunocapture of enzyme inhibitor, enzyme complexes and uses thereof
US4323647A (en) * 1980-10-15 1982-04-06 University Of Miami Steric hindrance enzyme immunoassay
DE3100062A1 (de) * 1981-01-02 1982-08-05 Hans A. Dipl.-Chem. Dr. 8000 München Thoma Homogenes verfahren zur bestimmung von liganden
DE3100061A1 (de) * 1981-01-02 1982-08-05 Hans A. Dipl.-Chem. Dr. 8000 München Thoma Verfahren zur bestimmung von liganden mittels kompetitionsreaktion
EP0079489A1 (en) * 1981-11-04 1983-05-25 Miles Laboratories, Inc. Methotrexate-labeled iodothyronine conjugates and method, reagent means and test device for the determination of iodothyronine in or iodothyronine uptake of a liquid sample
US4451652A (en) * 1982-05-24 1984-05-29 Abbott Laboratories Substituted theophylline salts
US4472301A (en) * 1982-05-27 1984-09-18 Miles Laboratories, Inc. Propranolol immunogen and antibodies
GB2135773B (en) * 1983-01-31 1985-12-04 Boots Celltech Diagnostics Enzyme inhibitor labelled immunoassay
US4650751A (en) * 1983-04-29 1987-03-17 Technicon Instruments Corporation Protected binding assay avoiding non-specific protein interference
US4550075A (en) * 1983-06-22 1985-10-29 Kallestad Laboratories, Inc. Method for ligand determination utilizing an immunoassay monitorable by biotin-containing enzymes, and compositions therefor
JPS607362A (ja) * 1983-06-27 1985-01-16 Fujirebio Inc 酵素を用いた抗原決定基具有物質の測定法
US4629694A (en) * 1983-07-12 1986-12-16 Cornell Research Foundation, Inc. Detecting and distinguishing between plasminogen activators
US4543412A (en) * 1983-11-04 1985-09-24 Abbott Laboratories Phenobarbital enzyme inhibitors
IL73293A (en) * 1983-11-04 1988-02-29 Abbott Lab Methyl 2-(alkanamidoalkylsulfonic)ethylthiophosphonate derivatives
US4559173A (en) * 1983-11-04 1985-12-17 Abbott Laboratories N-substituted dibenz[b,f]azepine salts
DE4007048A1 (de) * 1990-03-07 1991-09-12 Hoechst Ag N-acyl-aminoalkyl-2-hydroxyethylsulfide und ein verfahren zu ihrer herstellung
US5338663A (en) * 1990-08-24 1994-08-16 President And Fellows Of Harvard College Method of identifying inhibitors of β-protein esterase activity
US5648462A (en) * 1990-10-09 1997-07-15 Setsuko Funakoshi Peptide purification method using novel linker and solid-phase ligand
JP2552049B2 (ja) * 1990-10-09 1996-11-06 舩越 節子 合成ペプチド精製方法およびこれに用いるリンカー、リンカー結合用固相担体
JPH0737982B2 (ja) * 1992-12-14 1995-04-26 元成 狩野 抗胆汁酸抗体およびこれを用いた糞便中の胆汁酸検査方法
US5922703A (en) * 1993-09-24 1999-07-13 The Procter & Gamble Company Urethane-containing aminosteroid compounds
WO1995022546A1 (en) * 1994-02-18 1995-08-24 Cell Therapeutics, Inc. Intracellular signalling mediators
US6524808B1 (en) * 1999-06-25 2003-02-25 Roche Diagnostics Corporation Enzyme inhibition immunoassay
US6811998B2 (en) * 1999-06-25 2004-11-02 Roche Diagnostics Operations, Inc. Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
ES2298146T3 (es) * 1999-06-25 2008-05-16 Roche Diagnostics Operations, Inc. Inmunoensayo de inhibicion de enzimas.
WO2003089599A2 (en) * 2002-04-16 2003-10-30 The Regents Of The University Of California Ligand sensing fluorescent acetylcholinesterase for detection of organophosphate activity
ES2654584T3 (es) 2010-01-15 2018-02-14 Suzhou Neupharma Co., Ltd Ciertas entidades químicas, composiciones y métodos
WO2012027957A1 (en) 2010-08-28 2012-03-08 Suzhou Neupharma Co., Ltd. Bufalin derivatives, pharmaceutical compositions and use thereof
EP2670763B1 (en) * 2011-02-02 2018-08-01 Suzhou Neupharma Co., Ltd Certain chemical entities, compositions, and methods
EP3453713B1 (en) 2012-04-29 2021-09-08 Neupharma, Inc. Bufadienolide compounds substituted in position 3 by an amine group for use in the treatment of cancer
CN112114127A (zh) * 2020-09-09 2020-12-22 武汉生之源生物科技股份有限公司 一种甘胆酸均相酶免疫测定试剂盒及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN142734B (es) * 1975-04-28 1977-08-20 Miles Lab
NL7512939A (nl) * 1975-11-04 1977-05-06 Tno Werkwijze en inrichtingen voor het aantonen en/of bepalen van alkylerende verbindingen, zoals mosterdgassen.
US4134792A (en) 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
GB1595101A (en) * 1977-03-15 1981-08-05 Hoffmann La Roche Enzyme modifier immunoassay
IT1105734B (it) * 1977-07-14 1985-11-04 Syva Co Prova di legame di competizione di antienzima omogeneo

Also Published As

Publication number Publication date
CA1137077A (en) 1982-12-07
SE448259B (sv) 1987-02-02
ATA56080A (de) 1981-06-15
ES488263A0 (es) 1980-12-16
SE8000843L (sv) 1980-08-06
DE3003959C2 (de) 1982-12-23
IT8019675A0 (it) 1980-02-04
CH641569A5 (fr) 1984-02-29
FR2447966B1 (es) 1984-10-19
JPS55104896A (en) 1980-08-11
US4273866A (en) 1981-06-16
DE3003959A1 (de) 1980-08-14
BE881557A (fr) 1980-08-05
GB2043245A (en) 1980-10-01
AT365781B (de) 1982-02-10
AU528592B2 (en) 1983-05-05
ZA80371B (en) 1981-03-25
GB2043245B (en) 1983-05-25
FR2447966A1 (fr) 1980-08-29
IT1130254B (it) 1986-06-11
NL8000698A (nl) 1980-08-07
AU5476380A (en) 1980-08-14

Similar Documents

Publication Publication Date Title
ES8101647A1 (es) Un metodo de determinacion de ligandos en muestras de ensayo
NO903124L (no) Testmetode og reagenssett for denne.
DE69412137D1 (de) Sensoreinrichtung zum sandwichtest
PT89889A (pt) Processo para a preparacao de testes imunologicos contendo derivados de igg polimericos para a compensacao de factores perturbantes
AU3156489A (en) Solid-phase analytical device and method for using same
SE7714931L (sv) Forfarande och anordning for specifika bindningstest med tillhorande kolonnkromatografering
PT1044373E (pt) Metodo incluindo o uso de um novo calibrador e um dispositivo e kit de teste incluindo o calibrador
ES8405157A1 (es) Procedimiento de analisis inmunologico.
DE69416828D1 (de) Vorrichtung zur chromatographischen bestimmung, die einander entgegenstellbare teile enthalten
ATE350665T1 (de) Homogenes testsystem zur bestimmung eines analytes
CA2162568A1 (en) Method and reagent for simultaneously assaying one or more ligands in a group of preselected ligands
KR890012165A (ko) 이온-포획 분석방법 및 장치
DE69223510D1 (de) Verfahren und reagenzien zur ausführung von ioneneinfang-digoxin-assays
NL181461C (nl) Werkwijze en reagenskit voor het bepalen van antigenen, antilichamen of antigeen-antilichaam-complexen of -conjugaten.
DE69132238D1 (de) Verfahren zur Stabilisierung von Enzym-Konjugaten
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
SE7900343L (sv) Forfarande for standardisering av enmerkt komponent
ES8507265A1 (es) Un metodo de medir un ligando biologico
ATE160018T1 (de) Immunoassay für freie analyten
ATE161332T1 (de) Vorrichtungen zur ausführung von ioneneinfangassays
CA2269966A1 (en) Methods and reagents for determining protein s
ES8707342A1 (es) Un metodo de medida de la concentracion de un ligando libre en un fluido biologico
CA2021658A1 (en) Multiplex immunoassay system
KR900003630A (ko) 2-부위 확인 분석방법
ES481490A1 (es) Procedimiento para determinar el indice de fijacion de tiro-xina en el suero.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519